BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11107182)

  • 1. Absence of post-transcriptional RNA modifications of BCL10 in human malignant mesothelioma and colorectal cancer.
    Apostolou S; Murthy SS; Kolachana P; Jhanwar SC; Testa JR
    Genes Chromosomes Cancer; 2001 Jan; 30(1):96-8. PubMed ID: 11107182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of BCL10 mutations in human malignant mesothelioma.
    Apostolou S; De Rienzo A; Murthy SS; Jhanwar SC; Testa JR
    Cell; 1999 Jun; 97(6):684-6; discussion 686-8. PubMed ID: 10380921
    [No Abstract]   [Full Text] [Related]  

  • 3. Point mutations and deletions of the Bcl10 gene in solid tumors and malignant lymphomas.
    Lee SH; Shin MS; Kim HS; Park WS; Kim SY; Lee HK; Park JY; Oh RR; Jang JJ; Park KM; Han JY; Kang CS; Lee JY; Yoo NJ
    Cancer Res; 1999 Nov; 59(22):5674-7. PubMed ID: 10582682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BCL10 in malignant lymphomas--an evaluation using fluorescence in situ hybridization.
    Achuthan R; Bell SM; Carr IM; Leek JP; Roberts P; Horgan K; Markham AF; Selby PJ; MacLennan KA
    J Pathol; 2002 Jan; 196(1):59-66. PubMed ID: 11748643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCL10 is not a major target for frequent loss of 1p in testicular germ cell tumors.
    Kakinuma H; Habuchi T; Ito T; Mishina M; Sato K; Satoh S; Akao T; Ogawa O; Kato T
    Cancer Genet Cytogenet; 2001 Apr; 126(2):134-8. PubMed ID: 11376806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of Bcl10 gene mutations in Ewing's sarcomas.
    Park YK; Chi SG; Unni KK
    Oncol Rep; 2001; 8(6):1333-5. PubMed ID: 11605060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in Bcl10 are very rare in colorectal cancer.
    Stone JG; Rowan AJ; Tomlinson IP; Houlston RS
    Br J Cancer; 1999 Jul; 80(10):1569-70. PubMed ID: 10408399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bcl10 is not a target for frequent mutation in human carcinomas.
    Lambers AR; Gumbs C; Ali S; Marks JR; Iglehart JD; Berchuck A; Futreal PA
    Br J Cancer; 1999 Jul; 80(10):1575-6. PubMed ID: 10408401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for mutations of Bcl10 in leukaemia.
    Grimwade D; Du MQ; Langabeer S; Rogers J; Solomon E
    Br J Haematol; 2000 Jun; 109(3):611-5. PubMed ID: 10886211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BCL10 is not the gene inactivated by mutation in the 1p22 deletion region in mantle cell lymphoma.
    Bullinger L; Leupolt E; Schaffner C; Mertens D; Bentz M; Lichter P; Döhner H; Stilgenbauer S
    Leukemia; 2000 Aug; 14(8):1490-2. PubMed ID: 10942247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of mutations in the DNA polymerase delta gene of human sporadic colorectal cancers and colon cancer cell lines.
    Flohr T; Dai JC; Büttner J; Popanda O; Hagmüller E; Thielmann HW
    Int J Cancer; 1999 Mar; 80(6):919-29. PubMed ID: 10074927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BCL10 somatic mutations rarely occur in gastric lymphoma: detection of high frequency of polymorphisms in BCL10 coding region.
    Chen YW; Wong KY; Au WY; Liang RH; Srivastava G
    Cancer Genet Cytogenet; 2001 Jun; 127(2):184-7. PubMed ID: 11425462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of BCL10 mRNA mutation in lymphold malignancies.
    Kawano T; Iwase S; Nakayama R; Horiguchi-Yamada J; Kobayashi M; Yamada H
    Anticancer Res; 2002; 22(1A):305-9. PubMed ID: 12017308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infrequent BCL10 mutations in B-cell non-Hodgkin's lymphomas.
    Takahashi H; Hosokawa Y; Suzuki R; Morishima Y; Nakamura S; Seto M
    Jpn J Cancer Res; 1999 Dec; 90(12):1316-20. PubMed ID: 10665648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of Bcl10 gene mutations in laryngeal squamous cell carcinoma.
    Ronchetti D; Intini D; Pruneri G; Neri A; Pignataro L
    J Laryngol Otol; 2002 Aug; 116(8):610-2. PubMed ID: 12389689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of BCL10 mutations in Hodgkin's disease-derived cell lines.
    Re D; Benenson E; Wolf J; Diehl V; Staratschek-Jox A
    Br J Haematol; 2000 May; 109(2):420-2. PubMed ID: 10848834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of point mutations of BCL10 gene in hepatocellular carcinoma tissues: report of 46 cases.
    Jihua C; Xisheng L; Shengli C; Zongxian C; Guang C; Ruyu D
    Hum Mutat; 2000 May; 15(5):482-3. PubMed ID: 10790217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation analysis of the BCL10 gene in childhood solid malignancies.
    Miao J; Kusafuka T; Udatsu Y; Okada A
    Med Pediatr Oncol; 2002 Dec; 39(6):543-6. PubMed ID: 12376974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bcl10 expression, rearrangement and mutation in MALT lymphoma: correlation with expression of nuclear factor-kappaB.
    Ohshima K; Muta H; Kawasaki C; Muta K; Deyev V; Kanda M; Kumano Y; Podack ER; Kikuchi M
    Int J Oncol; 2001 Aug; 19(2):283-9. PubMed ID: 11445840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations of the BCL10 gene are not associated with the blast crisis of chronic myeloid leukaemia.
    Bose S; Goldman JM; Melo JV
    Leukemia; 1999 Nov; 13(11):1894-6. PubMed ID: 10557068
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.